← Eichor
Study identifier: NCT05962489 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Sleep-specific DBS Therapy in Parkinson's Disease

Condition: Deep Brain Stimulation · Parkinson's Disease and Parkinsonism · Dystonia  ·  Sponsor: University of Minnesota

PhaseNA
Planned participants64
Who can joinAll sexes, 21 Years to no upper limit
Healthy volunteersNo

About this study

Sleep-wake disturbances are a major factor associated with reduced quality of life of individuals with Parkinson's disease (PD), a progressive neurological disorder affecting millions of people in the U.S and worldwide. The brain mechanisms underlying these sleep disorders, and the effects of therapeutic interventions such as deep brain stimulation on sleep-related neuronal activity and sleep behavior, are not well understood. Results from this study will provide a better understanding of the brain circuitry involved in disordered sleep in PD and inform the development of targeted therapeutic interventions to treat sleep disorders in people with neurodegenerative disease.

This description comes directly from the study's public registry record.

Talk to the study team

Emily Weatherill, BS  ·  612-625-4947  ·  weath210@umn.edu

Luke Johnson, PhD  ·  612-625-9900  ·  joh03032@umn.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University Of MinnesotaMinneapolis, Minnesota, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05962489